Severe metabolic changes following oral sodium phosphate in a patient of renal cell carcinoma - On dialysis.
Oral sodium phosphate (OSP), an effective bowel purgative, is available over the counter (OTC) and requires a substantially lower volume than polyethylene glycol-based preparative agents. Rarely, OSP consumption has been associated with acute hypocalcemia and hyperphosphatemia. We describe a case of chronic kidney disease patient developing symptomatic hypocalcemia following OTC OSP.
Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
Christopher Thiam Seong
CT
Lim
D002292:Carcinoma, Renal Cell / Q000150:complications*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications*; D008875:Middle Aged; D010710:Phosphates / Q000009:adverse effects*; D006435:Renal Dialysis
D010710:Phosphates; C018279:sodium phosphate
Hyperphosphatemia; hypocalcemia; laxatives; sodium phosphate